2nd Tumour Models Summit Malmo
Social

2nd Tumour Models Summit Malmo

SomoEventFinder

Date

lun. 4 mai

Heure

06:00 - 15:00

Prix

Se websida

À propos de l'événement

🌍 Join industry leaders at the 2nd Tumour Models Summit in Malmö to discuss transformative strategies in preclinical oncology! This event promises to set the stage for a new era in selecting and optimizing predictive models that boost target selection, facilitate biomarker discovery, and enhance clinical translatability.

📅 Date & Time: October 10, 17:00 - 19:00
As 2025 comes to a close, the UK is stepping forward with vital changes to phase out animal testing, and significant FDA approvals are emerging from novel organoid efficacy data. With the rising tide of immunomodulating therapies and escalating preclinical development costs, the pressure on biopharma becomes palpable.

💡 The message is loud and clear: investing in more reliable, physiologically relevant, and cost-effective models is crucial for the future of asset advancement globally.

👥 Don't miss this opportunity to attend the Tumour Models Summit and collaborate with leading scientists and experts in navigating this pivotal shift in oncology.

🔗 Get Your Tickets Here!
🔗 View the Brochure!

🔊 Featured Speakers:

  • Christophe Come, Director - Pharmacology, Adcendo ApS
  • Andreas Norlin, Chief Scientific Officer, Ascelia Pharma
  • Nina Reschke, Head of Biology, Senior Director, Bright Peak Therapeutics
  • Lene Lene, Research Scientist, CataVax
  • Ludovic Bigot, Project Manager, Gustave Roussy
  • Adam Robertson, Chief Scientific Officer, Hemispherian
  • Peter Holst, Owner and Chief Executive and Science Officer, Hervolution Therapeutics
  • Paulina Zydowicz-Machtel, Preclinical Specialist, JJP Biologics
  • Srustidhar Das, Senior Research Scientist, Karolinska Institutet
  • Anil Thotakura, Head of Immuno-Oncology, King Fisher Marine Service LP
  • Rocio Evangelista, Head of Animal Facility, Molecular Partners AG
  • Maria Kiratzis, Research Associate, Roche
  • Manel Merabet, Chief Development Officer, SKYMAB Biotherapeutics
  • Ilona Prochazkova, Preclinical Development Scientist, SOTIO Biotech a.s

💸 Pricing:

  • Conference Only - Drug Developer Pricing: SEK 0.00
  • Conference Only - Service Provider Pricing: SEK 3499.00

We look forward to welcoming you to this pivotal event! Together, let's drive the future of preclinical oncology forward! 🚀

NOTE : Nous ne pouvons pas garantir l'exactitude des informations fournies sur cet événement. Visitez le site web de l'événement pour vérifier les détails tels que la date, les horaires, les prix et le lieu.